JR

Jhansi Rani Keshaboina

Active Director Director DIN 10995791
DIN 10995791 First appointment Mar 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jhansi Rani Keshaboina

Data last updated:

Jhansi Rani Keshaboina is a Director at Arrkem Life Sciences Private Limited (since 2025). The company operates in Paper.

DIN 10995791
Primary Designation Director
Industry Paper
First Appointment 11 Mar 2025
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arrkem Life Sciences Private Limited U21001TS2023PTC174840
Director11 Mar 20252023Active

Board colleagues of Jhansi Rani Keshaboina

NameDINCompanyDesignation
Ramana Kishore Narala10233802Arrkem Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arrkem Life Sciences Private Limited
Premium access

Shareholding and investment profile for Jhansi Rani Keshaboina

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jhansi Rani Keshaboina

Jhansi Rani Keshaboina currently holds 1 directorship: Arrkem Life Sciences Private Limited (Director, since 11 Mar 2025).

Jhansi Rani Keshaboina was first appointed on 11 Mar 2025 as Director at Arrkem Life Sciences Private Limited.

The current boards of Jhansi Rani Keshaboina's companies include Ramana Kishore Narala (Arrkem Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available